What is the current Price Target for the Vera Therapeutics Inc - Ordinary Shares - Class A stock?

The average Vera Therapeutics Inc - Ordinary Shares - Class A target price is $71.40. This is 144.35% higher than the current stock price. The highest price target is 259.34%, the lowest is -20.50%. 14 Analysts have issued a price target Vera Therapeutics Inc - Ordinary Shares - Class A 2026 .

What's going on with the Vera Therapeutics Inc - Ordinary Shares - Class A stock today?

The performance of Vera Therapeutics Inc - Ordinary Shares - Class A stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Vera Therapeutics Inc - Ordinary Shares - Class A Forecast, price target & analysts

Q: How high will the Vera Therapeutics Inc - Ordinary Shares - Class A stock rise?

No reliable answer can be given as to how high the Vera Therapeutics Inc - Ordinary Shares - Class A stock will rise. The performance of stocks, including the Vera Therapeutics Inc - Ordinary Shares - Class A stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

Q: Why did the Vera Therapeutics Inc - Ordinary Shares - Class A stock fall?

The decline in Vera Therapeutics Inc - Ordinary Shares - Class A stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

$29.22

3.62% yesterday

Nasdaq, Oct 24, 10:05 pm CET

ISIN

US92337R1014

Symbol

VERA

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Vera Therapeutics Inc - Ordinary Shares - Class A Target price 2025 - Analyst rating & recommendation

Vera Therapeutics Inc - Ordinary Shares - Class A Classifications & Recommendation:

Buy

84%

Hold

16%

Vera Therapeutics Inc - Ordinary Shares - Class A Price Target

Target Price	$71.40
Price	$29.22
Potential	144.35% register free of charge
Number of Estimates	14

	14 Analysts have issued a price target Vera Therapeutics Inc - Ordinary Shares - Class A 2026 . The average Vera Therapeutics Inc - Ordinary Shares - Class A target price is $71.40. This is 144.35% register free of charge higher than the current stock price. The highest price target is $105.00 259.34% register free of charge , the lowest is $23.23 20.50% register free of charge .
	A rating was issued by 19 analysts: 16 Analysts recommend Vera Therapeutics Inc - Ordinary Shares - Class A to buy, 3 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Vera Therapeutics Inc - Ordinary Shares - Class A stock has an average upside potential 2026 of 144.35% register free of charge . Most analysts recommend the Vera Therapeutics Inc - Ordinary Shares - Class A stock at Purchase.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.75	-4.41
	22.22%	60.36%
P/E		negative

14 Analysts have issued a Vera Therapeutics Inc - Ordinary Shares - Class A forecast for earnings per share. The average Vera Therapeutics Inc - Ordinary Shares - Class A EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.75	22.22%
2025	$-4.41 60.36% Unlock
2026	$-4.68 6.12% Unlock
2027	$-3.20 31.62% Unlock
2028	$0.58 118.13% Unlock
2029	$2.84 389.66% Unlock
2030	$4.32 52.11% Unlock
2031	$6.16 42.59% Unlock
2032	$7.47 21.27% Unlock

Current	-8.25	51.12%
2025	-6.39 22.50% Unlock
2026	-6.02 5.79% Unlock
2027	-8.82 46.51% Unlock
2028	48.22 646.71% Unlock
2029	9.92 79.43% Unlock
2030	6.53 34.17% Unlock
2031	4.58 29.86% Unlock
2032	3.78 17.47% Unlock

Vera Therapeutics Inc - Ordinary Shares - Class A...

Current Vera Therapeutics Inc - Ordinary Shares - Class A Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
B of A Securities	Locked ➜ Locked	Locked	Oct 16 2025
JP Morgan	Locked ➜ Locked	Locked	Aug 07 2025
Wolfe Research	Locked ➜ Locked	Locked	Aug 04 2025
Scotiabank	Locked ➜ Locked	Locked	Jun 02 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jun 02 2025
Wedbush	Locked ➜ Locked	Locked	May 07 2025
Cantor Fitzgerald	Locked ➜ Locked	Locked	May 07 2025

Analyst Rating	Date
Locked B of A Securities: Locked ➜ Locked	Oct 16 2025
Locked JP Morgan: Locked ➜ Locked	Aug 07 2025
Locked Wolfe Research: Locked ➜ Locked	Aug 04 2025
Locked Scotiabank: Locked ➜ Locked	Jun 02 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jun 02 2025
Locked Wedbush: Locked ➜ Locked	May 07 2025
Locked Cantor Fitzgerald: Locked ➜ Locked	May 07 2025

Discover more stocks with a high price target

TUI 50.73%

Deutsche Telekom 33.66%

Netflix 32.31%

BioNTech SE - ADR 32.25%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now